DPYSL2 and myeloid sarcoma: Collapsin response mediator protein-2 (CRMP2) is a downstream target of TTBK1 [32], whose expression induces the accumulation of phosphorylated CRMP2, and it was shown to be involved in the axonal degeneration pathology in MS [34].